EUVIMEDEUVIMED entdecken
Crossref

CAMK1 Suppresses Anoikis Resistance and Liver Metastasis in Colorectal Cancer

Qiang Feng, Yang Hao, Yanli Cheng, Da Liu, Minjun Jin, Tiantian Li, Chengshun Li, Qirong Li, Liqun Sun, Yongjian Gao iD, Jianfeng Mu, Fujian Ji und 2 weitere

The FASEB Journal · 31.05.2026 · 40 (10)

DOI: 10.1096/fj.202600481rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 22.05.2026. Verfasst von Qiang Feng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Anoikis, Colorectal Neoplasms, Liver Neoplasms, Calcium-Calmodulin-Dependent Protein Kinase Type 1. Die Arbeit nennt 41 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Jilin Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis represents a major challenge in the treatment of clinical colorectal cancer (CRC), and anoikis resistance enables cancer cell dissemination. This study identifies Calcium/calmodulin‐dependent protein kinase I (CAMK1) as a crucial regulator of anoikis in CRC progression. We analyzed CAMK1 expression in CRC tissues and its correlation with patient prognosis. In vitro, CAMK1 was overexpressed in CRC cell lines to assess its effects on proliferation, migration, invasion, and anoikis resistance. In vivo, mouse models were established to evaluate the impact of CAMK1 overexpression on tumor growth and liver metastasis. Mechanistically, we examined the interaction between CAMK1 and Phosphoinositide 3‐kinase (PI3K), as well as the phosphorylation of PI3K and the activation of the downstream Protein kinase B (AKT) pathway. Mitochondrial function indicators were simultaneously measured: membrane potential, reactive oxygen species (ROS) production, and apoptosis markers, including the Bax/Bcl‐2 ratio and Caspase‐3 activation. Rescue experiments were conducted using the PI3K activator 740 Y‐P. CAMK1 expression was significantly downregulated in CRC tissues, and low CAMK1 levels correlated with poor patient prognosis. In vitro, overexpression of CAMK1 significantly inhibited the malignant phenotypes of CRC cells and sensitized them to anoikis. Consistently, CAMK1 overexpression suppressed tumor growth and hepatic metastasis in mouse models. Mechanistically, CAMK1 interacted with PI3K, inhibiting its phosphorylation and subsequent AKT pathway activation. This inhibition induced mitochondrial dysfunction, characterized by depolarization of the mitochondrial membrane potential and increased ROS production, and promoted apoptosis, as evidenced by an elevated Bax/Bcl‐2 ratio and Caspase‐3 activation. Notably, the PI3K activator 740 Y‐P effectively reversed the pro‐anoikis effects and mitochondrial alterations induced by CAMK1 , confirming the pivotal role of the PI3K/AKT pathway in this regulation. CAMK1 functions as a novel tumor suppressor in CRC. It constrains anoikis resistance and metastasis by inhibiting the PI3K/AKT signaling pathway, thereby disrupting mitochondrial function. These findings highlight the dual potential of CAMK1 as both a prognostic biomarker and therapeutic target in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnoikisColorectal NeoplasmsLiver NeoplasmsCalcium-Calmodulin-Dependent Protein Kinase Type 1HumansAnimalsMiceMice, NudeCell Line, TumorMaleProto-Oncogene Proteins c-aktFemalePhosphatidylinositol 3-KinasesCell ProliferationSignal TransductionCell MovementMice, Inbred BALB CGene Expression Regulation, NeoplasticApoptosisReactive Oxygen Species

Stichwörter der Autor:innen

CAMK1anoikisanoikis resistancecolorectal cancermetastasis

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 1CAMK1 protein, humanProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesReactive Oxygen Species

Autor:innen und Institutionen

  • Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.
  • Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, China.
  • Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
  • Department of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
  • Outpatient Department of Pediatrics, Children's Medical Center, The First Hospital of Jilin University, Changchun, China.
  • Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.

ORCID-Profile: Yongjian Gao, Dongxu Wang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Jilin Provincial Natural Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province

Zitieren

APA

Feng, Q., Hao, Y., Cheng, Y., Liu, D., Jin, M., Li, T., Li, C., Li, Q., Sun, L., Gao, Y., Mu, J., Ji, F., Liu, X., & Wang, D. (2026). CAMK1 Suppresses Anoikis Resistance and Liver Metastasis in Colorectal Cancer. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202600481rr

Vancouver

Feng Q, Hao Y, Cheng Y, Liu D, Jin M, Li T, et al. CAMK1 Suppresses Anoikis Resistance and Liver Metastasis in Colorectal Cancer. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202600481rr

BibTeX
@article{Feng2026,
  author = {Feng, Qiang and Hao, Yang and Cheng, Yanli and Liu, Da and Jin, Minjun and Li, Tiantian and Li, Chengshun and Li, Qirong and Sun, Liqun and Gao, Yongjian and Mu, Jianfeng and Ji, Fujian and Liu, XingKai and Wang, Dongxu},
  title = {CAMK1 Suppresses Anoikis Resistance and Liver Metastasis in Colorectal Cancer},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {10},
  doi = {10.1096/fj.202600481rr}
}
Kostenlos starten →